|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
1,770,000,000 |
Market
Cap: |
286.01(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$132.51 - $182.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 560 |
Guru Rank Value : 3 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
459,004 |
461,916 |
540,416 |
1,279,317 |
Total Sell Value |
$81,195,771 |
$81,646,316 |
$93,320,391 |
$207,372,438 |
Total People Sold |
9 |
9 |
9 |
14 |
Total Sell Transactions |
10 |
11 |
13 |
34 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gosebruch Henry O |
EVP, Chief Strategy Officer |
|
2019-08-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
45,763 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2019-08-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,333 |
353,215 |
|
- |
|
Austin Roxanne S |
Director |
|
2019-08-01 |
4 |
B |
$65.66 |
$1,641,400 |
D/D |
25,000 |
117,114 |
2.39 |
- |
|
Austin Roxanne S |
Director |
|
2019-07-31 |
4 |
B |
$66.02 |
$1,980,690 |
D/D |
30,000 |
92,114 |
2.39 |
- |
|
Austin Roxanne S |
Director |
|
2019-07-30 |
4 |
B |
$66.35 |
$663,500 |
D/D |
10,000 |
62,114 |
2.39 |
- |
|
Gosebruch Henry O |
EVP, Chief Strategy Officer |
|
2019-07-29 |
4 |
B |
$67.28 |
$2,018,385 |
D/D |
30,000 |
75,763 |
2.74 |
- |
|
Durkin Brian L |
VP, Controller |
|
2019-07-25 |
4 |
D |
$67.46 |
$41,353 |
D/D |
(613) |
8,508 |
|
- |
|
Hudson Thomas J |
SVP, R&D and CSOOfficer |
|
2019-07-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,748 |
|
- |
|
Rapp Edward J |
Director |
|
2019-06-26 |
4 |
B |
$67.30 |
$504,750 |
D/D |
7,500 |
30,662 |
2.39 |
- |
|
Chase William J |
EVP, Finance & Administration |
|
2019-06-26 |
4 |
B |
$67.30 |
$2,045,920 |
D/D |
30,400 |
169,552 |
2.74 |
- |
|
Austin Roxanne S |
Director |
|
2019-06-26 |
4 |
B |
$67.50 |
$776,250 |
D/D |
11,500 |
52,114 |
2.39 |
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2019-05-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,375 |
368,548 |
|
- |
|
Waddell Frederick H |
Director |
|
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,419 |
19,548 |
|
- |
|
Alpern Robert J |
Director |
|
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,419 |
26,107 |
|
- |
|
Tilton Glenn F |
Director |
|
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,419 |
42,154 |
|
- |
|
Liddy Edward M |
Director |
|
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,419 |
22,669 |
|
- |
|
Austin Roxanne S |
Director |
|
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,419 |
40,614 |
|
- |
|
Hart Brett J |
Director |
|
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,419 |
10,062 |
|
- |
|
Rapp Edward J |
Director |
|
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,419 |
23,162 |
|
- |
|
Roberts Rebecca B |
Director |
|
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,419 |
4,318 |
|
- |
|
Meyer Melody B |
Director |
|
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,419 |
7,088 |
|
- |
|
Burnside William H.l. |
Director |
|
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,419 |
17,548 |
|
- |
|
Durkin Brian L |
VP, Controller |
|
2019-03-25 |
4 |
S |
$79.69 |
$37,853 |
D/D |
(475) |
9,121 |
|
- |
|
Schumacher Laura J |
Vice Chairman |
|
2019-03-14 |
4 |
S |
$80.00 |
$2,000,000 |
D/D |
(25,000) |
139,838 |
|
- |
|
Saleki-Gerhardt Azita |
EVP, Operations |
|
2019-03-05 |
4 |
S |
$79.03 |
$1,248,480 |
D/D |
(15,797) |
93,312 |
|
- |
|
641 Records found
|
|
Page 15 of 26 |
|
|